BCPC logo

BALCHEM CORP

BCPCNASDAQ
๐Ÿ† #1038 by market capEarnings Oct 20US Equity
$179.01โ–ฒ $1.84 (+1.03%)
Market closed ยท at close
1hโ€”
24hโ–ฒ 1.0%
7dโ–ฒ 0.4%
14dโ–ฒ 9.2%
30dโ–ฒ 10.9%
1yโ–ฒ 11.3%
๐ŸฆMarket Cap
$5.75B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+8.8%
Slowing
๐Ÿ“ŠGross Margin
36.3%
Healthy
๐Ÿ’ตFCF Margin
15.8%
Healthy
โš–๏ธP/S Ratio
5.3x
Fair
Otter Score
55
Weak

Trading Snapshot

Day Range
$178.25 โ€“ $181.56
52-Week Range
$139.17 โ€“ $183.90
Volume
$2.44B
Avg Volume
$2.47B
Shares Outstanding
32.1M
Next Earnings
Sep 29, 2026

Fundamentals Snapshot

Annual Revenue
$1.04B
Last Q Revenue
$284M
P/E Ratio
35.0
P/S Ratio
5.3x
EPS (TTM)
$5.10
Dividend Yield
0.54%

Why Investors Own BCPC

  • โœ“High-growth profile โ€” revenue up +42.8% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 76% gross margin and 13% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.04Bโ–ฒ +38.7% YoY
Gross Margin (TTM)
76.2%โ–ผ โˆ’0.4% YoY
Operating Income (TTM)
$99Mโ–ฒ +38.7% YoY
Free Cash Flow (TTM)
$135Mโ–ฒ +38.7% YoY

About BALCHEM CORP

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
55/100

Analyst Ratings

โ“˜
Consensus
Buy
9 analysts
Strong Buy2
Buy5
Hold2
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates